Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Sharon Bio-Medicine has informed that the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from October 1, 2022 till Forty Eight hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. Currently, the trading is temporarily suspended for capital reduction process and would be resumed upon requisite approval from regulators.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.60 |
| Dr. Reddys Lab | 1214.00 |
| Cipla | 1224.85 |
| Zydus Lifesciences | 931.60 |
| Lupin | 2343.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: